Transforming growth factor-β requires its target plasminogen activator inhibitor-1 for cytostatic activity

被引:44
作者
Kortlever, Roderik M.
Nijwening, Jeroen H.
Bernards, Rene
机构
[1] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Canc Genom, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands
关键词
D O I
10.1074/jbc.M803341200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytokine transforming growth factor beta(TGF beta) has strong antiproliferative activity in most normal cells but contributes to tumor progression in the later stages of oncogenesis. It is not fully understood which TGF beta target genes are causally involved in mediating its cytostatic activity. We report here that suppression of the TGF beta target gene encoding plasminogen activator inhibitor-1 (PAI-1) by RNA interference leads to escape from the cytostatic activity of TGF beta both in human keratinocytes (HaCaTs) and primary mouse embryo fibroblasts. Consistent with this, PAI-1 knock-out mouse embryo fibroblasts are also resistant to TGF beta growth arrest. Conversely, we show that ectopic expression of PAI-1 in proliferating HaCaT cells induces a growth arrest. PAI-1 knockdown does not interfere with canonical TGF beta signaling as judged by SMAD phosphorylation and induction of bona fide TGF beta target genes. Instead, knockdown of PAI-1 results in sustained activation of protein kinase B. Significantly, we find that constitutive protein kinase B activity leads to evasion of the growth-inhibitory action of TGF beta. Our data are consistent with a model in which induction of PAI-1 by TGF beta is critical for the induction of proliferation arrest.
引用
收藏
页码:24308 / 24313
页数:6
相关论文
共 24 条
[1]   TGF-β signaling in cancer -: a double-edged sword [J].
Akhurst, RJ ;
Derynck, R .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S44-S51
[2]   The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[3]   TGF-β and cancer [J].
Bierie, B ;
Moses, HL .
CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (1-2) :29-40
[4]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[5]   Urokinase plasminogen activator system - A multifunction role in tumor progression and metastasis [J].
Choong, PFM ;
Nadesapillai, APW .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2003, (415) :S46-S58
[6]   Links between tumor suppressors:: p53 is required for TGF-β gene responses by cooperating with Smads [J].
Cordenonsi, M ;
Dupont, S ;
Maretto, S ;
Insinga, A ;
Imbriano, C ;
Piccolo, S .
CELL, 2003, 113 (03) :301-314
[7]   The tumor suppressor Smad4 is required for transforming growth factor β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells [J].
Deckers, M ;
van Dinther, M ;
Buijs, J ;
Que, N ;
Löwik, C ;
van der Pluijm, G ;
ten Dijke, P .
CANCER RESEARCH, 2006, 66 (04) :2202-2209
[8]   TGF-β signaling in tumor suppression and cancer progression [J].
Derynck, R ;
Akhurst, RJ ;
Balmain, A .
NATURE GENETICS, 2001, 29 (02) :117-129
[9]   Differentiation plasticity regulated by TGF-β family proteins in development and disease [J].
Derynck, Rik ;
Akhurst, Rosemary J. .
NATURE CELL BIOLOGY, 2007, 9 (09) :1000-1004
[10]   Specificity and versatility in TGF-β signaling through Smads [J].
Feng, XH ;
Derynck, R .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2005, 21 :659-693